Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Belgian Law Seeks To Tackle Drug Shortages

Limits Risk Of ‘Excessive’ Sanctions For Suppliers

Executive Summary

Belgium is to impose new reporting obligations on pharmaceutical companies that become aware of drug supply interruptions, in a move that is seen by suppliers as less draconian than measures taken in other European countries

You may also be interested in...

Belgian Body Welcomes Clawback Exemption For Generics/Biosimilars Amid Price Cuts

Belgian body Medaxes is content with the latest pharmaceutical pricing legislation in the country, which cuts generics and biosimilars prices but also exempts such drugs from pharmaceutical clawback taxes.

Drug Shortage Crisis Worsens

As efforts continue to find ways of mitigating medicine shortages, a European survey has found not only that the situation is worsening, but that efforts to improve things are hindered by the patchwork of different rules on substitution and importation across the EU. 

Belgium Launches Probe On Biosimilar Restrictions

Belgium’s competition regulator has announced that it is investigating practices that have restricted or prevented biosimilars from entering the market.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts